News

Copper miner Freeport-McMoRan's (NYSE: FCX) stock is down 37% from its all-time high, yet the price of copper is almost at an all-time high. While the company's news hasn't been entirely positive

Shares in animal pharmaceutical company Zoetis (NYSE: ZTS) have been under a cloud since the release of the company's fourth-quarter earnings report in mid-February. The Q4 numbers were fine, but

Following the presidential election last November, Bitcoin's (CRYPTO: BTC) price soared 54% in just six weeks. After trading in a relatively narrow range through the first couple of months of 2025,

There's no denying that when Warren Buffett speaks, investors tend to listen. That's the attention you receive when you've built a trillion-dollar business -- Berkshire Hathaway (NYSE: BRK.A)(NYSE:

Micron Technology (NASDAQ: MU) recently reported another quarter of strong demand for its memory products. Baird analyst Tristan Gerra updated his guidance as a result, maintaining an outperform

Over the last couple of years, the pharmaceutical sector has captivated investors thanks in large part to novel medications used to treat chronic weight management and diabetes.

While you may be

While Wall Street analysts project a healthy 10% total return for the S&P 500 in 2025, reality has painted a different picture. Nearly three months into the year, the benchmark index has retreated

Need dividend income? You can't do much better than tobacco giant Altria (NYSE: MO). Not only has it paid a dividend like clockwork every quarter for decades now, it has raised its per-share payout

After stellar performances in 2023 and 2024 that resulted in a two-year gain of 84.5%, the Nasdaq Composite fell as low as 17,303.01 on March 13 -- a drop of 14.2% drop from the high of 20,173.89 it

Richard Bernstein is the CEO and chief investment officer at Richard Bernstein Advisors. In this podcast, he joins Motley Fool host Ricky Mulvey for a conversation about:

To catch full episodes of

Merck (NYSE: MRK) is a top healthcare company with one of the best drugs ever made in its portfolio: Keytruda. While there are concerns about its patent losses in the future, its sales are still

Coffee chain Dutch Bros (NYSE: BROS) is on a roll, and I don't mean with ham and cheese. The stock has more than doubled in six months as Dutch Bros keeps crushing earnings and revenue estimates in

Want to buy a good dividend stock and secure a great price in the process? I have a list of three stocks that can help you diversify your portfolio, allow you to earn above-average dividends, and

I have bought more SoundHound AI (NASDAQ: SOUN) stock this year than any other artificial intelligence (AI) stock. The recent sell-off in pricey tech stocks won't make me stop. In fact, I wouldn't

Some investors are looking closely at the stocks they own and asking themselves if they could weather an economic slowdown. U.S. President Donald Trump's threats of tariffs against trading partners

Smart investments change lives.

Take Visa (NYSE: V), for example. It's hardly the most exciting stock around, but it has consistently beaten the S&P 500 over the last decade.

The result? Big

Solana (CRYPTO: SOL) is currently priced near $146 per coin, but if the stars align, it's easy to see how it could grow to be worth more than $500.

There's no need to rely on fanciful hopes of a

Investors are rightfully concerned about how Adobe's (NASDAQ: ADBE) management team will handle the threat and opportunity of artificial intelligence.

*Stock prices used were the afternoon prices